Sermorelin Acetate

Description

Sermorelin is a 29-amino-acid fragment of GHRH — the shortest sequence retaining full receptor-activating potency — and was among the earliest GHRH analogues studied clinically. Its short half-life makes it a common reference compound for researchers establishing baseline GHRH receptor kinetics before testing longer-acting analogues like CJC-1295.

Sermorelin research spans both isolated GH-axis studies and comparative work against tesamorelin, another GHRH fragment with a different amino-acid modification pattern and stability profile.

For research use only. Reconstitute with bacteriostatic water immediately before use and store the lyophilised peptide refrigerated, protected from light.